Examkin

Soru

Zorluk: KolayPulmonary and Critical Care

A 6868-year-old man comes to the emergency department due to four days of progressively worsening dyspnea, frequent coughing, and increased production of thick, yellowish sputum. His medical history includes a 4545-pack-year smoking habit and a pituitary microadenoma discovered incidentally on a brain MRI last year. He does not experience orthopnea or lower extremity swelling. On arrival, his temperature is 37.3∘C37.3^\circ\text{C} (99.1∘F99.1^\circ\text{F}), blood pressure is 146/90 mm Hg146/90 \text{ mm Hg}, heart rate is 108/min108/\text{min}, and respiratory rate is 26/min26/\text{min}. Pulse oximetry shows an oxygen saturation of 88%88\% on room air. Chest examination reveals a barrel-shaped chest, hyperresonance to percussion, and a prolonged expiratory phase with diffuse bilateral wheezes. Neck veins are flat, and cardiac auscultation shows no gallops or murmurs. The extremities have no edema. Laboratory results are as follows:

Leukocyte count: 10,800/mm310,800/\text{mm}^3
Thyroid-stimulating hormone (TSH): 1.4μU/mL1.4 \mu\text{U/mL} (normal: 0.4−4.0μU/mL0.4-4.0 \mu\text{U/mL})
Free T4: 0.6 ng/dL0.6 \text{ ng/dL} (normal: 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL})

Arterial blood gas on room air:
pH: 7.277.27
PaCO 2_2: 66 mm Hg66 \text{ mm Hg}
PaO 2_2: 52 mm Hg52 \text{ mm Hg}
HCO 3−_3^-: 30 mEq/L30 \text{ mEq/L}

Which of the following is the most appropriate initial management step for this patient?

  1. A
    Initiation of intravenous bumetanide and sublingual nitroglycerin
  2. B
    Infusion of intravenous vancomycin and cefepime
  3. Administration of inhaled short-acting bronchodilators and systemic corticosteroidsCevap
  4. D
    Infusion of intravenous sodium bicarbonate
  5. E
    Measurement of anti-thyroid peroxidase antibodies

Cevap

Administration of inhaled short-acting bronchodilators and systemic corticosteroids
The correct answer is the administration of inhaled short-acting bronchodilators and systemic corticosteroids. This patient presents with a classic acute exacerbation of chronic obstructive pulmonary disease (AECOPD), characterized by increased dyspnea, cough, and sputum production in a patient with a significant smoking history. Physical exam findings of a barrel chest, hyperresonance, and diffuse wheezing, along with an arterial blood gas showing acute-on-chronic respiratory acidosis, firmly establish the diagnosis. Initial management of AECOPD fundamentally includes inhaled short-acting bronchodilators (e.g., albuterol, ipratropium) to rapidly relieve bronchospasm and systemic corticosteroids to reduce airway inflammation. While antibiotics are also indicated given his increased sputum production, targeted narrow-spectrum therapy (such as a macrolide or respiratory fluoroquinolone) is preferred over broad-spectrum agents.

Adım Adım Çözüm

1
Identify the primary clinical syndrome from the patient's presentation.
The patient has progressive dyspnea, increased sputum purulence, diffuse wheezing, and hyperinflation in the context of a significant smoking history.
Recognizing the classic triad of a COPD exacerbation (increased dyspnea, cough, sputum purulence) is the essential first step in guiding management.
2
Interpret the arterial blood gas (ABG) results to assess severity and rule out other conditions.
The ABG shows a pH of 7.27, PaCO2 of 66 mm Hg, and HCO3- of 30 mEq/L, which indicates an acute-on-chronic respiratory acidosis.
The ABG confirms the severity of the respiratory failure and helps differentiate the presentation from severe metabolic disturbances.
3
Determine the most appropriate initial pharmacological interventions for the identified condition.
Standard initial therapy includes inhaled short-acting bronchodilators, systemic corticosteroids, and appropriate narrow-spectrum antibiotics.
These targeted therapies address the acute bronchospasm, underlying airway inflammation, and likely infectious trigger of the COPD exacerbation without exposing the patient to unnecessary risks.

Anahtar Kavram

The initial management of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) involves inhaled short-acting bronchodilators, systemic corticosteroids, and targeted antibiotic therapy, while recognizing and avoiding misdirected treatments for heart failure or inappropriate broad-spectrum antibiotics.
Bu soruyu puanla

Konular

Pulmonary and Critical Care

Bu konudan daha fazla soru